Comparing Safety and Tolerability of Antipsychotic Treatment

John W. Newcomer, MD, and Jeffrey A. Lieberman, MD, Chair

Published: March 15, 2007

Article Abstract

Certain modifiable risk factors for diabetes andcardiovascular disease need to be considered when prescribing antipsychoticmedications. Antipsychotics may change a patient’s weight, glucose,cholesterol, and triglycerides. These changes may lead to changes incardiopulmonary health. If switching medications is not a viable option, themetabolic and cardiopulmonary risks may be minimized by monitoring certainbehaviors such as smoking, exercise, diet, and medication adherence. Theprincipals of primary prevention suggest the importance of lowering risk fordisease by using monitoring and intervention approaches.

This CME activity is expired. For more CME activities, visit cme.psychiatrist.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Volume: 68

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Frontothalamic Circuit Abnormalities in Patients With Bipolar Depression and Suicide Attempts

To identify potential markers for suicide risk, this fMRI study looked at neural activity in bipolar depression...

Read More...